Studies which patient factors predict benefit from exercise rehabilitation in heart failure
Looks at whether blood microRNA levels relate to fitness gains in adults with heart failure.
Plain-language title generated from the registry record
Registry title: Predictive Factors of Response to Phase II Cardiac Rehabilitation in Heart Failure With Reduced Ejection Fraction
Key facts
- Where
- Corbie, FranceSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 40 and 75 years old?
Source: NCT07164911, who can take part
Where in France
- Hospital center of CorbieCorbie, FranceTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Centre Hospitalier de Corbie
- Trial code
- NCT07164911
- Record updated
- 16 December 2025
- Original description
Exercise intolerance, measured as peak oxygen consumption (VO₂peak) during exercise in patients with heart failure with reduced ejection fraction (HFrEF). Change in VO₂peak (ΔVO₂peak), which serves as a prognostic marker for HFrEF engaged in exercise based cardiac rehabilitation program (ExCR). Responders to ExCR generally show improved cardiac function but some patients with HFrEF do not respond to ExCR. VO₂peak depends on three major components of oxygen transport: Pulmonary (lungs), circulatory (heart and vessels) and skeletal muscle (oxygen utilization) functions. These physiological responses to ExCR may be influenced by epigenetic regulation, specifically the expression of circulating microRNAs (c-miRNAs).Read full original descriptionShow less
Prédiction Des réponses du Patient Porteur d'Une Insuffisance Cardiaque à Fraction d'éjection altérée à Une Phase II de réadaptation Cardiaque
Exercise intolerance, measured as peak oxygen consumption (VO₂peak) during exercise in patients with heart failure with reduced ejection fraction (HFrEF). Change in VO₂peak (ΔVO₂peak), which serves as a prognostic marker for HFrEF engaged in exercise based cardiac rehabilitation program (ExCR). Responders to ExCR generally show improved cardiac function but some patients with HFrEF do not respond to ExCR. VO₂peak depends on three major components of oxygen transport: Pulmonary (lungs), circulatory (heart and vessels) and skeletal muscle (oxygen utilization) functions. These physiological responses to ExCR may be influenced by epigenetic regulation, specifically the expression of circulating microRNAs (c-miRNAs).
Linking non-invasive measurements and epigenetic markers could 1) identify which component of the oxygen transport chain is most impaired and 2) allow personalized interventions to maximize VO₂peak improvements.
The primary objective of this stidy is to assess the association between changes in VO₂peak during exercise training and circulating microRNA expression (miR-146a, miR-191, miR-23a, miR-140, miR-1, miR-21, miR-133a, miR-17-5p, miR-3200-3p).
The secondary objective is to examine the relationship between pulmonary, cardiovascular, and neuromuscular adaptations to exercise and circulating microRNA expression.
Inclusion: Heart failure with reduced ejection fraction < 40%; NYHA functional class ≥ II; Clinically stable for at least 6 weeks; On optimized medical therapy for at least 6 weeks; Prescription for phase II cardiac rehabilitation; BMI between 20-30 kg·m-²; Physical activity level: sedentary or physically active but untrained; Signed informed consent to participate in the study; Affiliation to the French national health insurance system.
Exclusion: Uncontrolled arterial hypertension; Secondary respiratory disease such as emphysema or chronic obstructive pulmonary disease (COPD); Secondary cardiovascular disease; Contraindication to regular adapted physical activity; Individuals under legal protection or deprived of liberty; Pregnant or breastfeeding women.